Conference abstract
Bacillus as a source of novel antibiotics
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Bacillus subtilis and Bacillus amyloliquefaciens have more than 10% of their genome devoted to antibiotic production. These compounds could be ribosomally synthesized or obtained by the so-called multicarrier thiotemplate mechanism, in which small monomer units, amino-acids and aryl-acids in NRPS and acyl-CoAs in PKS, are loaded, activated and condensed by mega-enzymes organized in iterative functional units. Two of these compounds, namely mycosubtilin and amylolysin, will be presented in details from a structural, mechanistic and biological mode of action. Mycosubtilin is a lipopeptide that possess an antifungal activity on pathogenic yeasts such as Candida albicans while amylolysin is a lanthibiotic whose biological activity is centered on pathogenic bacteria such as Listeria monocytogenese or Staphylococcus aureus.
Subjects
Infectious DiseasesMicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bacteriology & Parasitology
- SubjectInfectious Diseases
- SubjectMicrobiology
- BylineArticles whose byline prints “Patrick Fickers”
